The development of neoplasms is determined by a complex interplay of hereditary defects, chromosomal aberrations, and the state of the body's antitumor defense mechanisms. Understanding these factors helps evaluate the probability of malignant transformation and the mechanisms of tumor progression.
Genetic burdenApproximately 20 hereditary diseases are associated with a high risk of cancer development.
Chromosomal markersTranslocations, such as the Philadelphia chromosome, trigger leukemogenesis.
Immune surveillanceDecreased activity of antitumor immunity critically increases the risk of tumor growth.
Geographic riskEpidemiological differences exist: for example, gastric cancer is more common in Japan.
Hereditary Predisposition
Genetic factors play a pivotal role in oncogenesis. There are about 20 hereditary pathologies that significantly increase the likelihood of malignant transformation.
Li–Fraumeni syndrome: An autosomal dominant disorder associated with a p53 gene mutation. It provokes a wide spectrum of tumors, including sarcomas, leukemias, and breast cancer.
Genome instability syndromes: Fanconi anemia, Bloom syndrome, and ataxia-telangiectasia create conditions for the development of childhood leukemia.
Family history: The risk of developing tumors in siblings is 2–4 times higher, and in monozygotic twins, the incidence of leukemia can reach 25%.
Tumor Suppressor Gene Defects
Normally, tumor suppressor genes limit uncontrolled cell division. Their impairment removes the "brakes" from the cell cycle:
The TP53 gene: A critical regulator whose defect underlies Li–Fraumeni syndrome.
The MADH4 gene: A deletion at locus 18q21.1 associated with colorectal and pancreatic cancer.
Impaired adhesion: Decreased expression of E-cadherin disrupts intercellular contacts, which directly promotes tumor metastasis.
Chromosomal Abnormalities
Structural chromosome changes frequently serve as the trigger for tumor growth:
Philadelphia chromosome: The result of a reciprocal translocation between chromosomes 9 and 22. The fusion of the BCR and ABL1 genes leads to tyrosine kinase activation, provoking myeloid leukemia.
Deletions: Frequently identified in osteosarcomas and retinoblastomas, depriving the cell of essential regulatory DNA regions.
Exogenous and Immune Factors
In addition to genetics, environmental and immunological conditions influence risk:
Immunodeficiency: Low activity of antitumor defense mechanisms prevents the body from eliminating transformed cells in a timely manner.
Geographic features: An uneven distribution of neoplasms is observed. For example, gastric cancer is endemic to Japan and Argentina, while esophageal cancer is endemic to southeastern China.
Mnemonic
"Tumor suppressors are the brakes: if p53 or E-cadherin are broken, the cell races toward metastasis without stopping."
Frequently asked questions
Which chemical substances are classified as exogenous carcinogens?
Exogenous chemical carcinogens include several classes of substances.
Aflatoxins — metabolic products of molds, predominantly Aspergillus flavus.
Other organic substances — epoxides, plastics, urethane, carbon tetrachloride, chloroethylamines.
Metals; occupational hazards for lung cancer also include asbestos, arsenic, chromium, and nickel.
Which viruses have proven oncogenic activity in humans?
Both DNA- and RNA-containing viruses possess oncogenic activity in humans.
Key virus-tumor associations in humans:
Epstein–Barr virus — DNA virus; associated with endemic (African) Burkitt lymphoma and nasopharyngeal carcinoma.
Human papillomavirus — DNA virus; associated with papillomas, skin cancer, and genital cancers.
HTLV-I — RNA virus; associated with certain types of T-cell leukemias and lymphomas.
Which specific cells of the immune system carry out antitumor surveillance?
Antitumor immune surveillance is carried out by several types of effector cells.
Plays a major role in destroying tumor cells:
Natural killer (NK) cells — destroy cells without prior sensitization by polyclonally recognizing stress molecules MICA and MICB. In the liver, pit cells perform this function.
Cytotoxic T lymphocytes (CTL) — mature from CD8+ cells, specifically recognizing membrane-bound tumor antigens associated with class I MHC.
Macrophages — mediate non-specific damage (by releasing TNF-α) and specific damage (by binding to Fc fragments of antitumor antibodies). In the liver, phagocytosis is provided by hepatic macrophages (Kupffer cells).
Why do so many different tumors arise in Li–Fraumeni syndrome?
Because the p53 gene is a universal "guardian of the genome." Its defect deprives cells of the ability to repair DNA damage or trigger apoptosis, rendering them vulnerable to any carcinogens.
How does the Philadelphia chromosome cause leukemia?
The translocation produces a chimeric gene encoding a hyperactive tyrosine kinase. This protein continuously signals the cell to divide, bypassing normal regulatory checkpoints.
What is decreased E-cadherin expression?
It is the loss of proteins responsible for cell-to-cell adhesion. Without them, tumor cells lose contact with their neighbors and acquire the ability to detach from the primary tumor node, leading to metastasis.
Go deeper
Mechanisms of ultraviolet radiation effects on carcinogenesis.
The role of tyrosine kinases in proliferative signal transduction.
Epidemiological theories of gastric cancer distribution.
The relationship between agammaglobulinemia and oncopathology.
Molecular mechanisms of loss of heterozygosity at the 10q23 locus.